Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

SHA:688198 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	557.07	500.26	369.91	295.07	251.8	181.9
Other Revenue	2.15	1.61	0.73	0.1	0.02	0.02
Revenue	559.22	501.88	370.64	295.17	251.82	181.92
Revenue Growth (YoY)	42.05%	35.41%	25.57%	17.21%	38.42%	24.57%
Cost of Revenue	66.49	58.52	37.64	31.36	29.61	20.21
Gross Profit	492.74	443.35	333	263.81	222.21	161.71
Selling, General & Admin	169.61	154.92	131.97	123.77	131.16	83.41
Research & Development	148.51	151.44	98.81	55.15	58.9	28.77
Other Operating Expenses	6.69	3.46	1.25	1.62	1.17	1.06
Operating Expenses	326.27	312.22	233.5	181.64	192.04	114.69
Operating Income	166.47	131.14	99.5	82.17	30.17	47.02
Interest Expense	-0.65	-0.46	-0.41	-0.08	-0.12	-
Interest & Investment Income	13.35	17.32	17.66	22.53	16.49	19.55
Currency Exchange Gain (Loss)	-0.1	0.05	-0.26	0	-	-
Other Non Operating Income (Expenses)	0.44	-0.16	-0.06	-0.68	-0.05	-0.06
EBT Excluding Unusual Items	179.5	147.89	116.43	103.94	46.5	66.51
Gain (Loss) on Sale of Investments	0.44	0.74	1	0.89	0.97	0.34
Gain (Loss) on Sale of Assets	-0.02	-0.05	0.05	-0.01	-0.02	0.01
Other Unusual Items	12.66	2.2	2.54	1.32	2.31	-0.57
Pretax Income	192.58	150.79	120.02	106.14	49.76	66.29
Income Tax Expense	23.02	18.64	10.61	11.74	-1.51	10.37
Earnings From Continuing Operations	169.55	132.14	109.41	94.39	51.26	55.92
Minority Interest in Earnings	12.99	14.19	5.8	0.73	-0.06	0.61
Net Income	182.54	146.33	115.21	95.13	51.2	56.53
Net Income to Common	182.54	146.33	115.21	95.13	51.2	56.53
Net Income Growth	71.92%	27.02%	21.11%	85.80%	-9.42%	-10.40%
Shares Outstanding (Basic)	138	137	136	136	135	134
Shares Outstanding (Diluted)	138	137	137	136	135	134
Shares Change (YoY)	1.12%	-0.29%	0.92%	0.86%	0.44%	33.66%
EPS (Basic)	1.33	1.07	0.85	0.70	0.38	0.42
EPS (Diluted)	1.33	1.07	0.84	0.70	0.38	0.42
EPS Growth	70.02%	27.38%	20.00%	84.21%	-9.82%	-32.96%
Free Cash Flow	28.11	-27.02	12.53	24.01	4.27	43.07
Free Cash Flow Per Share	0.20	-0.20	0.09	0.18	0.03	0.32
Dividend Per Share	0.800	0.800	0.800	0.500	0.357	0.143
Dividend Growth	-	-	60.00%	40.02%	149.90%	-
Gross Margin	88.11%	88.34%	89.84%	89.38%	88.24%	88.89%
Operating Margin	29.77%	26.13%	26.85%	27.84%	11.98%	25.85%
Profit Margin	32.64%	29.16%	31.08%	32.23%	20.33%	31.07%
Free Cash Flow Margin	5.03%	-5.38%	3.38%	8.14%	1.70%	23.67%
EBITDA	194.32	150.45	110.7	87.78	36.19	52.69
EBITDA Margin	34.75%	29.98%	29.87%	29.74%	14.37%	28.96%
D&A For EBITDA	27.85	19.31	11.19	5.61	6.02	5.67
EBIT	166.47	131.14	99.5	82.17	30.17	47.02
EBIT Margin	29.77%	26.13%	26.85%	27.84%	11.98%	25.85%
Effective Tax Rate	11.96%	12.36%	8.84%	11.06%	-	15.64%
Revenue as Reported	559.22	501.88	370.64	295.17	251.82	181.92
Advertising Expenses	-	2.01	0.37	1.12	1.22	0.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.